Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The person has been diagnosed with Autism Spectrum Disorder (ASD) by a licensed mental health or medical professional
- A parent has completed a specific communication and social skills questionnaire (called the SCQ-L), and the score is above 14
- The person meets the standard diagnostic guidelines for ASD (known as DSM-5 criteria), based on a symptom checklist
- The person is willing and motivated to take part in the treatment program
- A parent or caregiver is willing to take part alongside the person
- The person has a verbal thinking and language ability score above 70, as measured by a specific intelligence test (called the KBIT-2-R)
Who may not be able to join:
- People who have a history of a psychotic disorder, or who are currently experiencing psychotic symptoms
- People who are currently having thoughts of suicide with a plan or intention to act on them
- People who currently have a severe alcohol or other substance use disorder
- People who are currently enrolled in another clinical trial specifically for autism spectrum disorder
- People who express that they are unwilling to complete the study's required procedures
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Antonio Pagan, PhD, The University of Texas Health Science Center, Houston
Phone: (713) 486-2700
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in adaptive functioning as assessed by the Adaptive Behavior Assessment System, Third Edition (ABAS-3); Change in social response as assessed by the Social Responsiveness Scale, Second Edition (SRS-2); Change in transition readiness as assessed by the Transition Readiness Scale (TRS)-child version; Change in transition readiness as assessed by the Transition Readiness Scale (TRS)-parent version
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.